Biotransformation of 6‐thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6‐thioguanine
Bindia Jharap(Meander Medisch Centrum), AA van Bodegraven(Amsterdam UMC Location Vrije Universiteit Amsterdam), Kees Smid(Vrije Universiteit Amsterdam), Abraham J. Wilhelm, Godefridus J. Peters(Gdańsk Medical University), RM Vos(Amsterdam UMC Location Vrije Universiteit Amsterdam), C. J. J. Mulder(Amsterdam UMC Location Vrije Universiteit Amsterdam), Antonie Zwiers(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 24
Related Papers
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
|European Journal of Cancer and Clinical Oncology|1991|460
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430